The VeriSeq PGS Kit takes advantage of next-generation sequencing (NGS) technology on the Illumina MiSeq System to provide comprehensive, accurate screening of all 24 chromosomes for selection of euploid embryos. Cells used in this system can come from various stages of embryo development: polar body 1; polar body 2; blastomere biopsy from day 3 embryos; trophectodermal (TE) biopsy from blastocysts. Preimplantation genetic screening (PGS) results generated using VeriSeq PGS are comparable to those achieved with the widely used array-based 24sure technology. In addition, NGS offers the opportunity for improved assay workflow, higher throughput, and enhanced performance.
Please rotate your device for details

| Specifications | |||
|---|---|---|---|
| Input Quantity | 1 ng SurePlex WGA product | MultiPlexing | 12 or 24 samples |
| Assay Time | 12 samples 12 hrs 24 samples 14 hrs |
Effective Resolution | 20MB |
| Compatible System | MiSeq | Analysis Software | BlueFuse Multi v4.1 |
Product and Ordering Information